Original Article
Safety and Efficacy of Methylprednisolone Infiltration in Anserine Syndrome Treatment
Eficacia y seguridad de la infiltración con metilprednisolona en pacientes con síndrome anserino: ensayo clínico aleatorizado
David Vega-Morales
, Jorge Antonio Esquivel-Valerio, Roberto Negrete-López, Dionicio Ángel Galarza-Delgado, Mario Alberto Garza-Elizondo
Corresponding author
Departamento de Medicina Interna, Servicio de Reumatología, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico
Read
9825
Timeswas read the article
3140
Total PDF
6685
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 1 | 10 | 11 |
| 2025 5 | 116 | 73 | 189 |
| 2025 4 | 94 | 33 | 127 |
| 2025 3 | 144 | 36 | 180 |
| 2025 2 | 72 | 40 | 112 |
| 2025 1 | 106 | 49 | 155 |
| 2024 12 | 45 | 31 | 76 |
| 2024 11 | 52 | 64 | 116 |
| 2024 10 | 32 | 56 | 88 |
| 2024 9 | 61 | 49 | 110 |
| 2024 8 | 75 | 60 | 135 |
| 2024 7 | 77 | 44 | 121 |
| 2024 6 | 84 | 53 | 137 |
| 2024 5 | 69 | 47 | 116 |
| 2024 4 | 62 | 42 | 104 |
| 2024 3 | 45 | 54 | 99 |
| 2024 2 | 34 | 52 | 86 |
| 2024 1 | 44 | 22 | 66 |
| 2023 12 | 53 | 35 | 88 |
| 2023 11 | 65 | 44 | 109 |
| 2023 10 | 42 | 36 | 78 |
| 2023 9 | 91 | 40 | 131 |
| 2023 8 | 53 | 32 | 85 |
| 2023 7 | 45 | 24 | 69 |
| 2023 6 | 49 | 28 | 77 |
| 2023 5 | 40 | 24 | 64 |
| 2023 4 | 57 | 9 | 66 |
| 2023 3 | 79 | 34 | 113 |
| 2023 2 | 55 | 28 | 83 |
| 2023 1 | 53 | 17 | 70 |
| 2022 12 | 62 | 39 | 101 |
| 2022 11 | 56 | 35 | 91 |
| 2022 10 | 64 | 46 | 110 |
| 2022 9 | 66 | 52 | 118 |
| 2022 8 | 66 | 35 | 101 |
| 2022 7 | 80 | 46 | 126 |
| 2022 6 | 90 | 37 | 127 |
| 2022 5 | 82 | 46 | 128 |
| 2022 4 | 55 | 52 | 107 |
| 2022 3 | 51 | 59 | 110 |
| 2022 2 | 57 | 46 | 103 |
| 2022 1 | 35 | 42 | 77 |
| 2021 12 | 36 | 34 | 70 |
| 2021 11 | 57 | 51 | 108 |
| 2021 10 | 52 | 54 | 106 |
| 2021 9 | 39 | 44 | 83 |
| 2021 8 | 33 | 39 | 72 |
| 2021 7 | 25 | 30 | 55 |
| 2021 6 | 36 | 53 | 89 |
| 2021 5 | 40 | 44 | 84 |
| 2021 4 | 120 | 100 | 220 |
| 2021 3 | 77 | 37 | 114 |
| 2021 2 | 44 | 27 | 71 |
| 2021 1 | 91 | 36 | 127 |
| 2020 12 | 34 | 20 | 54 |
| 2020 11 | 86 | 19 | 105 |
| 2020 10 | 47 | 14 | 61 |
| 2020 9 | 50 | 30 | 80 |
| 2020 8 | 42 | 19 | 61 |
| 2020 7 | 31 | 14 | 45 |
| 2020 6 | 41 | 29 | 70 |
| 2020 5 | 40 | 21 | 61 |
| 2020 4 | 42 | 17 | 59 |
| 2020 3 | 20 | 4 | 24 |
| 2020 1 | 4 | 0 | 4 |
| 2019 9 | 4 | 0 | 4 |
| 2019 6 | 1 | 0 | 1 |
| 2019 3 | 1 | 0 | 1 |
| 2019 1 | 1 | 0 | 1 |
| 2018 5 | 5 | 1 | 6 |
| 2018 4 | 35 | 5 | 40 |
| 2018 3 | 51 | 9 | 60 |
| 2018 2 | 35 | 2 | 37 |
| 2018 1 | 35 | 5 | 40 |
| 2017 12 | 30 | 3 | 33 |
| 2017 11 | 30 | 7 | 37 |
| 2017 10 | 23 | 7 | 30 |
| 2017 9 | 52 | 7 | 59 |
| 2017 8 | 51 | 6 | 57 |
| 2017 7 | 47 | 5 | 52 |
| 2017 6 | 71 | 6 | 77 |
| 2017 5 | 79 | 8 | 87 |
| 2017 4 | 60 | 16 | 76 |
| 2017 3 | 38 | 26 | 64 |
| 2017 2 | 26 | 5 | 31 |
| 2017 1 | 31 | 10 | 41 |
| 2016 12 | 75 | 12 | 87 |
| 2016 11 | 63 | 9 | 72 |
| 2016 10 | 87 | 15 | 102 |
| 2016 9 | 87 | 3 | 90 |
| 2016 8 | 87 | 8 | 95 |
| 2016 7 | 52 | 7 | 59 |
| 2016 6 | 2 | 0 | 2 |
| 2016 2 | 1 | 0 | 1 |
| 2015 12 | 2 | 0 | 2 |
| 2015 10 | 0 | 17 | 17 |
| 2015 9 | 4 | 0 | 4 |
| 2015 8 | 4 | 11 | 15 |
| 2015 7 | 34 | 5 | 39 |
| 2015 6 | 56 | 7 | 63 |
| 2015 5 | 77 | 15 | 92 |
| 2015 4 | 47 | 12 | 59 |
| 2015 3 | 38 | 6 | 44 |
| 2015 2 | 79 | 9 | 88 |
| 2015 1 | 69 | 14 | 83 |
| 2014 12 | 59 | 10 | 69 |
| 2014 11 | 40 | 9 | 49 |
| 2014 10 | 55 | 20 | 75 |
| 2014 9 | 34 | 15 | 49 |
| 2014 8 | 36 | 15 | 51 |
| 2014 7 | 48 | 17 | 65 |
| 2014 6 | 74 | 14 | 88 |
| 2014 5 | 53 | 15 | 68 |
| 2014 4 | 61 | 15 | 76 |
| 2014 3 | 48 | 21 | 69 |
| 2014 2 | 53 | 18 | 71 |
| 2014 1 | 50 | 13 | 63 |
| 2013 12 | 55 | 14 | 69 |
| 2013 11 | 49 | 19 | 68 |
| 2013 10 | 62 | 14 | 76 |
| 2013 9 | 57 | 19 | 76 |
| 2013 8 | 51 | 22 | 73 |
| 2013 7 | 46 | 14 | 60 |
| 2013 6 | 47 | 17 | 64 |
| 2013 5 | 62 | 19 | 81 |
| 2013 4 | 41 | 18 | 59 |
| 2013 3 | 42 | 27 | 69 |
| 2013 2 | 50 | 18 | 68 |
| 2013 1 | 38 | 11 | 49 |
| 2012 12 | 42 | 5 | 47 |
| 2012 11 | 29 | 14 | 43 |
| 2012 10 | 29 | 7 | 36 |
| 2012 9 | 11 | 5 | 16 |
| 2012 7 | 3 | 0 | 3 |
| 2012 6 | 19 | 0 | 19 |
| 2012 5 | 11 | 0 | 11 |
| 2012 4 | 14 | 0 | 14 |
Show all
